Abiomed Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $17.15 billion, with shareholders equity totaling $1.54 billion.
The company employs approximately 1.536 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.
Over the past 12 months, Abiomed Inc. reported $1.07 billion in revenue, generating net income of $266.76 million.
Key financial metrics include a P/E ratio of 64.27, a price-to-book (P/B) ratio of 11.14, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ABMD.